More about

Icahn School Of Medicine At Mount Sinai

News
April 19, 2023
3 min read
Save

Combination therapy shows preliminary antitumor activity in pediatric neuroblastoma

The combination of olaparib and the investigational ATR inhibitor ceralasertib induced antitumor responses in children and adolescents with DNA repair-deficient tumors, according to phase 1 results of the AcSé-ESMART trial.

News
April 16, 2023
3 min read
Save

Vaccine-immunotherapy combination extends RFS in high-risk melanoma

The addition of an mRNA-based cancer vaccine to pembrolizumab extended RFS among patients with resected high-risk melanoma, according to study results presented at American Association for Cancer Research Annual Meeting.

News
March 27, 2023
4 min watch
Save

VIDEO: Racial, ethnic disparities more pronounced in ambulatory vs. inpatient setting

LAS VEGAS — Results showed racial and ethnic disparities are more pronounced in the ambulatory care setting compared with the inpatient setting for lumbar surgical care.

News
March 04, 2023
2 min read
Save

In patients with COVID-19, vaccination reduces risk for CV events

NEW ORLEANS — The first U.S. study to examine the link between COVID-19 vaccination and risk for major adverse cardiac events found that vaccination was protective against such events in patients with COVID-19.

News
February 21, 2023
3 min read
Save

Findings from negative urothelial carcinoma trial suggest ‘chemotherapy backbone matters’

SAN FRANCISCO — The addition of atezolizumab to platinum-based chemotherapy failed to significantly improve survival for patients with metastatic urothelial carcinoma, according to a final analysis of the randomized phase 3 IMvigor130 trial.

News
February 19, 2023
3 min read
Save

Adjuvant nivolumab improves outcomes in high-risk urothelial cancer

SAN FRANCISCO — Adjuvant nivolumab improved outcomes compared with placebo for patients with high-risk muscle-invasive urothelial carcinoma, according to study results.

News
February 17, 2023
3 min read
Save

‘Intriguing’ data may advance more personalized approach to muscle-invasive bladder cancer

SAN FRANCISCO — Transurethral resection of bladder tumor followed by systemic therapy induced stringently defined clinical complete response among more than 40% of patients with muscle-invasive bladder cancer, according to phase 2 study results.

News
February 12, 2023
3 min watch
Save

Itacitinib appears effective for acute graft-versus-host disease

A short course of itacitinib induced high response rates among patients with low-risk acute graft-versus-host disease, according to study results.

News
February 03, 2023
4 min read
Save

At Issue: Challenges of managing SCAD, which predominantly affects women

Spontaneous coronary artery dissection is a life-altering event that predominantly affects women, but there is little consensus about how to best diagnose and treat it.

News
February 02, 2023
3 min read
Save

Major adverse pregnancy outcomes confer long-term ischemic heart disease risk in women

Women who had any of five major adverse pregnancy outcomes had elevated risk for ischemic heart disease for as long as 46 years after delivery, researchers reported in The BMJ.

View more